Join the team at Medivation [www.medivation.com] for an exciting opportunity to take molecules from bench to bedside! In this role, you will evaluate the preclinical and clinical PK, PK/PD, and metabolism properties of small molecule drug candidates. You will collaborate with colleagues in Clinical, Preclinical, Chemistry, Regulatory, and CMC in a team-oriented environment to support programs in all phases of development. You will be responsible for preclinical DMPK studies, preclinical PK/TK analyses, and clinical pharmacology studies, including first-in-human studies. You will prepare nonclinical, biopharmaceutical, and clinical pharmacology sections for regulatory submissions. For consideration, submit your CV to Human Resources ([email protected]).
Experience: · Position requires PhD and minimum of ten years of related experience in Biotech/Pharmaceutical industry. · Experience must include leadership role in the design and management of human studies, authorship of relevant IND and NDA sections, and company representation at FDA meetings. · Hands-on experience with PK/PD modeling and simulation is required; population PK modeling is a plus. Joyce Mordenti, PhD | Vice President, Translational Medicine and DMPK | Medivation, Inc., 201 Spear St., Third Floor, San Francisco, CA 94105 (P: 415.829.4125 | F: 415.543.3411 | * [email protected] | http://www.medivation.com
